^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
SNUH-CD19-CAR-T
i
Other names: SNUH-CD19-CAR-T
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Seoul National University Hospital
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
9ms
Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation (clinicaltrials.gov)
P2, N=50, Recruiting, Seoul National University Hospital
New P2 trial • CAR T-Cell Therapy
|
SNUH-CD19-CAR-T
Share via
